Genuity Science Investor
Some of the world's most advanced clinico-omic data and insights to enable better disease discovery to improve human health.
Founded Date:
2013-01-01
Total Funding:
455000000.0
Employee Number:
101-250
Funding Status:
M&A
Technology:
Cancer
Last Funding Type:
Series C
Acquisitions Number:
Made Acquisitions, Was Acquired
Investors Number:
8.0
Last Funding Date:
2018-11-27
Zip:
NA
Industry:
End-to-End Drug Development
Headquarters:
Boston, Massachusetts, United States
Estimated Revenue:
$10M to $50M